Arcutis Biotherapeutics, Inc. ARQT Unrealized Losses on Investments (Before Tax)
Unrealized Losses on Investments (Before Tax) at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s unrealized losses on investments (before tax).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s unrealized losses on investments (before tax)?
- Arcutis Biotherapeutics, Inc. (ARQT) reported unrealized losses on investments (before tax) of $251K in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s unrealized losses on investments (before tax) changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s unrealized losses on investments (before tax) increased by 4920.0% year-over-year, from $5K to $251K.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s unrealized losses on investments (before tax)?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s unrealized losses on investments (before tax) has grown at a 18.5% compound annual growth rate (CAGR), from $9K to $21K.